The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Therapeutic Pipeline Program, 2019Miro1-targeting Drug Discovery for Parkinson's Disease
Study Rationale:
There is mounting evidence for involvement of mitochondrial biology in the pathogenesis of Parkinson’s disease (PD). Alterations in mitochondrial dynamics and distribution have been... -
Therapeutic Pipeline Program, 2019Screening for Precision Parkin Activators
Study Rationale:
Defects in the protein parkin cause the loss of nerve cells in the brain and are responsible for many cases of young-onset Parkinson's disease that develops before 50 years of age. We... -
Research Grant, 2019Patient Reports on Cannabis Use in Parkinson's Disease
Study Rationale:
Medical marijuana (cannabis) is now legal in 47 states, and recreational use is legal in nine. Interest in cannabis for treating Parkinson’s disease (PD) is rapidly increasing... -
Research Grant, 2019Pathogenesis of the Virome in Parkinson’s Disease
Study Rationale:
Numerous studies have implicated viruses as causal factors or potential triggers for Parkinson’s disease (PD). Our study will provide a comprehensive understanding of all the viral... -
Aligning Science Across Parkinson's, 2019Global Parkinson’s Genetics Program (GP2)
GP2 is a resource of the Aligning Science Across Parkinson's (ASAP) Initiative. It is an ambitious five-year program to genotype >150,000 volunteers around the world to further understand the genetic...
-
Therapeutic Pipeline Program, 2019Identification of Novel Compounds that Improve Mitochondrial Quality Control
Study Rationale:
Dysfunction of mitochondria, the powerhouses of the cell, has been linked to degeneration in nerve cells in Parkinson’s disease. When mitochondria can’t function properly, cellular...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.